Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Advanced Solid Tumors 27Advanced Solid Tumor 26Solid Tumor 13Solid Tumors 6Advanced Solid Tumour 5Advanced Malignant Solid Tumor 4Metastatic Solid Tumors 2Mesothelioma 2Advanced or Metastatic Solid Tumors 2mCRPC (Metastatic Castration-resistant Prostate Cancer) 1Uveal Melanoma 1Solid Tumor, Adult 1Pediatric Solid Tumor, Unspecified, Protocol Specific 1Neoplasm Metastasis 1Mesothelioma, Malignant 1Melanoma 1Malignant Solid Tumors 1Malignant Solid Tumor 1Locally Advanced/Metastatic Solid Tumours 1Locally Advanced or Metastatic Solid Tumors 1Locally Advanced Solid Tumor 1HER2-Positive Solid Tumors 1Docetaxel 1Colorectal Neoplasms 1Advanced/Metastatic Solid Tumors 1Advanced Solid Tumours 1Advanced Solid Tumors Cancer 1Advanced Solid Tumors - Phase 1 Population 1Advanced Solid Tumor (Phase 1) 1Advanced Malignant Solid Tumours 1

Interventions

vorolanib 3neratinib 3toripalimab 1dacomitinib 1Vinorelbine 1TAK-243 1Premedication 1Paclitaxel 1Injections 1Immune Checkpoint Inhibitors 1Clinical Trials, Phase II as Topic 1Capecitabine 11-(4-(4-(3-oxa-8-azabicyclo(3.2.1)octan-8-yl)-6-morpholino-1,3,5-triazin-2-yl)phenyl)-3-(pyridin-4-yl)urea 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Malignant Solid Tumors × Injections × Other solid neoplasm × Clear all
NCT07480733 2026-05-29

Phase II Study of JS212/JS213 as Monotherapy and in Combination in Patients With Advanced Malignant Solid Tumors

Shanghai Junshi Bioscience Co., Ltd.

Phase 2 Recruiting
410 enrolled
Other solid neoplasm

Advanced Malignant Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡